Tempus AI, Inc.
TEM Healthcare Health Information Services
Tempus AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 83.4% from fiscal 2024.
- Revenue
- +23.1%
- EPS
- +82.2%
- Free cash flow
- +95.7%
- Total debt
- +8.44%
Quarter to September 2026, against a year earlier
Follow TEM
Alert me
Tempus AI, Inc. (TEM) Revenue growth
Tempus AI, Inc.'s revenue growth over the twelve months to 30 September 2026 was 36.6%, down 46.8 percentage points from fiscal 2025 (83.4%). That is above the Health Information Services industry median of 6.48% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 83.4% | 53.03 |
| FY2024 | 30.4% | (35.47) |
| FY2023 | 65.9% | — |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 23.1% | 1.58 |
| Jun 2026 | 21.6% | (14.56) |
| Mar 2026 | 36.1% | (46.86) |
| Dec 2025 | 83.0% | (1.74) |
| 7 more quarters | Free account |
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| HNGE Hinge Health Inc. compare | 58.8% |
| HTFL Heartflow, Inc. compare | 42.8% |
| TEM Tempus AI, Inc. | 36.6% |
| BTSG BrightSpring Health Services, Inc. compare | 26.0% |
| WAY Waystar Holding Corp. compare | 21.4% |
| PRVA Privia Health Group, Inc. compare | 19.2% |
| VEEV Veeva Systems Inc. compare | 16.5% |
| HQY HealthEquity, Inc. compare | 7.34% |
| DOCS Doximity, Inc. compare | 6.48% |
| Health Information Services industry median | 6.48% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on TEM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Beneish M-score
- The full statement